Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20–59 Years in the United Kingdom’s CPRD 1995–2015

References

• American Lung Association. Trends in Asthma Morbidity and Mortality; 2012.
   Google Scholar
• von Eckardstein A, Wu FCW. Testosterone and atherosclerosis. Growth Horm IGF Res. 2003;13:S72–S84. doi:10.1016/S1096-6374(03)00059-5
   Web of Science ®Google Scholar
• Kapoor D, Malkin CJ, Channer KS, Jones TH. Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf). 2005. doi:10.1111/j.1365-2265.2005.02299.x
   Web of Science ®Google Scholar
• Layton JB, Meier CR, Sharpless JL, Stürmer T, Jick SS, Brookhart MA. Comparative safety of testosterone dosage forms. JAMA Intern Med. 2015;175(7):1187–1196. doi:10.1001/jamainternmed.2015.1573
   PubMed Web of Science ®Google Scholar
• Drake L, Hordinsky M, Fiedler V, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. 1999;41(4):550–554. doi:10.1016/S0190-9622(99)80051-6
   PubMed Web of Science ®Google Scholar
• Houghton DE, Alsawas M, Barrioneuvo P, et al. Testosterone therapy and venous thromboembolism: a systematic review and meta-analysis. Thromb Res. 2018;172:94–103. doi:10.1016/j.thromres.2018.10.023
   PubMed Web of Science ®Google Scholar
• Stuijver DJF, Majoor CJ, Van Zaane B, et al. Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study. Chest. 2013;143(5):1337–1342. doi:10.1378/chest.12-1446
   PubMed Web of Science ®Google Scholar
• Lieber BA, Han J, Appelboom G, et al. Association of steroid use with deep venous thrombosis and pulmonary embolism in neurosurgical patients: a national database analysis. World Neurosurg. 2016;89:126–132. doi:10.1016/j.wneu.2016.01.033
   Web of Science ®Google Scholar
• Haddad A, Kantar R, Tamim H, Jamali FR, Taher A. Venous thromboembolism and preoperative steroid use, a retrospective cohort study from the ACS-NSQIP database: are surgical patients at risk? Blood. 2014;124(21):2865. doi:10.1182/blood.v124.21.2865.2865
   Web of Science ®Google Scholar
• Fowkes FJI, Price JF, Fowkes FGR. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg. 2003;25(1):1–5. doi:10.1053/ejvs.2002.1778
   PubMed Web of Science ®Google Scholar
• Johannesdottir SA, Horváth-Puho E, Dekkers OM, et al. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med. 2013;173(9):743. doi:10.1001/jamainternmed.2013.122
   PubMed Web of Science ®Google Scholar
• Heit JA. The epidemiology of venous thromboembolism in the community: implications for prevention and management. In: The Vein Book; 2007. doi:10.1016/B978-012369515-4/50039-9
   Google Scholar
• Weiss AJ, Elixhauser A. Overview of Hospital Stays in the United States, 2012. HCUP Statistical Brief #180. October 2014. Agency for Healthcare Research and Quality, Rockville, MD. Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb180-Hospitalizations-United-States-2012.pdf. Accessed January 05, 2022.
   Google Scholar
• Huerta C, Johansson S, Wallander MA, García Rodríguez LA. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med. 2007;167(9):935. doi:10.1001/archinte.167.9.935
   PubMedGoogle Scholar
• White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res. 2009;123:S11–S17. doi:10.1016/S0049-3848(09)70136-7
   PubMed Web of Science ®Google Scholar
• White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23_suppl_1). doi:10.1161/01.CIR.0000078468.11849.66
   Web of Science ®Google Scholar
• Higgins PDR, Skup M, Mulani PM, Lin J, Chao J. Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol. 2015;13(2):316–321. doi:10.1016/j.cgh.2014.07.017
   Web of Science ®Google Scholar
• Orsi FA, Lijfering WM, Geersing G-J, et al. Glucocorticoid use and risk of first and recurrent venous thromboembolism: self-controlled case-series and cohort study. Br J Haematol. 2021;193(6):1194–1202. doi:10.1111/bjh.17388
   Web of Science ®Google Scholar
• Waljee AK, Rogers MAM, Lin P, et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017;357:j1415. doi:10.1136/bmj.j1415
   PubMed Web of Science ®Google Scholar
• Simion C, Campello E, Bensi E, et al. Use of glucocorticoids and risk of venous thromboembolism: a narrative review. Semin Thromb Hemost. 2021;47(6):654–661. doi:10.1055/s-0040-1722270
   PubMed Web of Science ®Google Scholar
• Sneeboer MMS, Hutten BA, Majoor CJ, Bel EHD, Kamphuisen PW. Oral and inhaled corticosteroid use and risk of recurrent pulmonary embolism. Thromb Res. 2016;140:46–50. doi:10.1016/j.thromres.2016.02.010
   Web of Science ®Google Scholar
• García Rodríguez LA, Pérez Gutthann S. Use of the UK general practice research database for pharmacoepidemiology. Br J Clin Pharmacol. 1998;45(5):419–425. doi:10.1046/j.1365-2125.1998.00701.x
   PubMed Web of Science ®Google Scholar
• Lawrenson R, Todd JC, Leydon GM, Williams TJ, Farmer RDT. Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol. 2000;49(6):591–596. doi:10.1046/j.1365-2125.2000.00199.x
   PubMed Web of Science ®Google Scholar
• Goldhaber SZ. Risk factors for venous thromboembolism. J Am Coll Cardiol. 2010;56(1):1–7. doi:10.1016/j.jacc.2010.01.057
   PubMed Web of Science ®Google Scholar
• Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23_suppl_1). doi:10.1161/01.CIR.0000078469.07362.E6
   Web of Science ®Google Scholar
• Canonico M, Oger E, Conard J, et al. Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study. J Thromb Haemost. 2006;4(6):1259–1265. doi:10.1111/j.1538-7836.2006.01933.x
   Web of Science ®Google Scholar
• Olié V, Canonico M, Scarabin PY. Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women. Curr Opin Hematol. 2010;17(5):457–463. doi:10.1097/MOH.0b013e32833c07bc
   PubMed Web of Science ®Google Scholar
• Simon T, De Jonage-Canonico MBY, Oger E, et al. Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism. J Thromb Haemost. 2006;4(1):71–76. doi:10.1111/j.1538-7836.2005.01693.x
   Web of Science ®Google Scholar
• Bergendal A, Bremme K, Hedenmalm K, et al. Risk factors for venous thromboembolism in pre-and postmenopausal women. Thromb Res. 2012;130(4):596–601. doi:10.1016/j.thromres.2012.05.024
   PubMed Web of Science ®Google Scholar
• Martinez C, Suissa S, Rietbrock S, et al. Testosterone treatment and risk of venous thromboembolism: population based case-control study. BMJ. 2016:i5968. doi:10.1136/bmj.i5968
   Web of Science ®Google Scholar
• Majoor CJ, Kamphuisen PW, Zwinderman AH, et al. Risk of deep vein thrombosis and pulmonary embolism in asthma. Eur Respir J. 2013;42(3):655–661. doi:10.1183/09031936.00150312
   PubMed Web of Science ®Google Scholar